Scientist: Aurélia Nguyen

Aurélia Nguyen Profile picture

In October 2020, Aurélia Nguyen was appointed Managing Director of the Office of the COVAX Facility. In this role, she is leading the coordination of procurement and delivery of COVID-19 vaccines. Until then, she served as Gavi’s Managing Director for Vaccines & Sustainability.
Prior to joining Gavi, Aurélia worked at GlaxoSmithKline. She has also undertaken research for the World Health Organization on generic medicines policies. Aurélia holds a Master’s degree in Health Policy, Planning & Financing from the London School of Hygiene & Tropical Medicine and the London School of Economics.
TIME magazine put her on the 2021 TIME100 Next list honouring “the 100 individuals who are shaping the future of their fields and defining the next generation of leadership”.
Covax vaccine against COVID-19. Glass medical vials with liquid on the background Covax company logo. Ampoules with coronavirus vaccine on a medical glass table

COVAX and the challenges of worldwide vaccine access

Vaccines are showing us a way out of the coronavirus pandemic, but vaccine access is still shockingly inequitable. Over a billion doses have been administered since December 2020, but the vast majority have gone to citizens of high-income countries. The COVAX initiative, a unique collaboration led by the Vaccine Alliance Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO), aims to combat this injustice.

Covax vaccine against COVID-19. Glass medical vials with liquid on the background Covax company logo. Ampoules with coronavirus vaccine on a medical glass table

A scientist’s opinion: Interview with Aurélia Nguyen about the Global Alliance for Vaccines and Immunisation (Gavi)

Gavi was founded in response to a market failure: by the late 90s, many powerful vaccines were becoming available, but they were too expensive for low-income countries, and millions of children were unable to benefit from them. In 1997, the Bill and Melinda Gates Foundation and partner organisations set up a mechanism through which vaccine ...